chr4-139301326-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001184989.2(NDUFC1):c.-222+1090A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.898 in 399,296 control chromosomes in the GnomAD database, including 161,566 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.91 ( 62992 hom., cov: 32)
Exomes 𝑓: 0.89 ( 98574 hom. )
Consequence
NDUFC1
NM_001184989.2 intron
NM_001184989.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.332
Genes affected
NDUFC1 (HGNC:7705): (NADH:ubiquinone oxidoreductase subunit C1) The encoded protein is a subunit of the NADH:ubiquinone oxidoreductase (complex I), the first enzyme complex in the electron transport chain located in the inner mitochondrial membrane. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 4-139301326-T-C is Benign according to our data. Variant chr4-139301326-T-C is described in ClinVar as [Benign]. Clinvar id is 1263855.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.966 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NDUFC1 | NM_001184989.2 | c.-222+1090A>G | intron_variant | ENST00000394223.2 | |||
NDUFC1 | NM_001184987.1 | c.-163+1090A>G | intron_variant | ||||
NDUFC1 | NM_001184988.1 | c.-199+1090A>G | intron_variant | ||||
NDUFC1 | NM_001184990.1 | c.-159+1090A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NDUFC1 | ENST00000394223.2 | c.-222+1090A>G | intron_variant | 3 | NM_001184989.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.908 AC: 138194AN: 152164Hom.: 62932 Cov.: 32
GnomAD3 genomes
AF:
AC:
138194
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.892 AC: 220430AN: 247014Hom.: 98574 Cov.: 0 AF XY: 0.892 AC XY: 112322AN XY: 125876
GnomAD4 exome
AF:
AC:
220430
AN:
247014
Hom.:
Cov.:
0
AF XY:
AC XY:
112322
AN XY:
125876
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.908 AC: 138311AN: 152282Hom.: 62992 Cov.: 32 AF XY: 0.912 AC XY: 67884AN XY: 74462
GnomAD4 genome
AF:
AC:
138311
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
67884
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at